Home/Filings/4/0001415889-23-012375
4//SEC Filing

Duncan Gregory Scott 4

Accession 0001415889-23-012375

CIK 0001818844other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 7:05 AM ET

Size

5.1 KB

Accession

0001415889-23-012375

Insider Transaction Report

Form 4
Period: 2023-08-17
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2023-08-17$1.25/sh+25,000$31,24557,461 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001831127

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:05 AM ET
Size
5.1 KB